Location: Las Vegas
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Las Vegas
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha Phase 2 · DaVita Clinical Research · R1 Therapeutics · NCT06712654 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · Comprehensive Cancer Centers of Nevada · Eli Lilly and Company · NCT07218380 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Optum Care Cancer Center ( Site 9535) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi Phase 2 · OptumCare Cancer Care at Charleston · National Cancer Institute (NCI) · NCT05564390 Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults Phase N/A · Galderma Investigational Site 8848 · Galderma R&D · NCT06988605 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed Phase 3 · Alliance for Childhood Diseases/Cure 4 the Kids Foundation · National Cancer Institute (NCI) · NCT06172296 A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine Phase 3 · IMA Clinical Research - Las Vegas · Kallyope Inc. · NCT07674654 An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms NA · Citruslabs · Zenchi, Inc. · NCT07078682 Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Can Phase 2 · Women's Cancer Center of Nevada · Aadi Bioscience, Inc. · NCT05997017 STOP-HAE: A Phase 3 Study of ADX-324 in HAE Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD NA · CC Lou Ruvo Center for Brain Health · Ad scientiam · NCT05566769 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au Phase 3 · Local Institution - 0144 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) Phase 3 · Alliance for Childhood Diseases dba Cure 4 The Kids Foundati · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma Phase 2 · Alliance for Childhood Diseases/Cure 4 the Kids Foundation · Children's Oncology Group · NCT06368817 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma Phase 2/Phase 3 · Alliance for Childhood Diseases/Cure 4 the Kids Foundation · National Cancer Institute (NCI) · NCT05691478 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Excel Clinical Research · Amgen · NCT07037433 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease Phase 2 · Vector Clinical Trials · Eli Lilly and Company · NCT07483099 LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis Phase 2 · Digestive Disease Specialists - Las Vegas - Crimson Canyon D · Eli Lilly and Company · NCT07415044 Post-Market Study to Assess iTind Safety in Comparison to UroLift NA · Pacific West Urology · Olympus Corporation of the Americas · NCT04757116 A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena Phase 3 · Women's Cancer Center of Nevada ( Site 6011) · Merck Sharp & Dohme LLC · NCT07216703 A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Phase 2 · Comprehensive Cancer Centers of Nevada · Biostar Pharma, Inc. · NCT06764940 Vascular Function in Adults With Down Syndrome Phase N/A · University of Nevada Las Vegas - UNLV · University of Nevada, Las Vegas · NCT07630207 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight Phase 3 · Palm Research Center Tenaya · Eli Lilly and Company · NCT07369011 Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living Phase 3 · Kailera Clinical Site · Kailera · NCT07284979 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT Phase 2 · University Medical Center of Southern Nevada · Children's Oncology Group · NCT04322318 An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Phase 3 · M3 Wake Research - Las Vegas Wellness Way · Neuvosyn Laboratories, LLC · NCT07747103 Renal Pelvic Denervation Pilot Trial NA · DaVita Clinical Research · Verve Medical, Inc · NCT07005050 PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis Phase 4 · University of Nevada Las Vegas · Aurinia Pharmaceuticals Inc. · NCT07611214 Shoulder Innovations Clinical Data Registry Phase N/A · University Medical Center of Southern Nevada · Shoulder Innovations · NCT06754150
Look up another city
Look up another condition